Anaheim, CA, March 20, 2018 (GLOBE NEWSWIRE) -- LiveWire Ergogenics, Inc. (OTC:LVVV), a company focused on research, product development, acquisition and management of legal, fully controlled and contained turnkey production facilities for cannabis-based products and services, announced today that it has secured a cannabis distribution permit from the City of Coachella, California, in addition to the cultivation/nursery permit it obtained last month.
This distribution permit allows the Company to accelerate its plans to develop cannabis products from popular and rare strains of cannabis into a variety of different products for wholesale distribution to licensed entities throughout the State of California. Securing this permit establishes a well-structured system for a legally compliant production and distribution company of cannabis products.
Bill Hodson, CEO of LiveWire stated, “This distribution permit is a key component for advancing our product line that includes CBD/THC-infused edibles and lotion products into a larger marketplace. We now have the ability to distribute not only the LiveWire brand, but also a full spectrum of THC products from multiple manufacturers, cultivators and extractors for medicinal and recreational use, as well. We plan to put this distribution permit to use immediately, as we assemble all the vital steps in securing a solid chain of custody and a direct route to market for a complete 7X Pure verified product line.”
Richard O’Connor, CEO of Coachella Brands, Inc., adds, “We will be producing many great and exciting products on the Coachella Brands, Inc. property. LiveWire has demonstrated a real commitment to the property and we look forward to utilizing their services for distributing our products.”
For more information on the Coachella Brands, Inc. property, please visit CoachellaBrandsInc.com
LiveWire plans to secure additional permits and licenses in order to pursue its plan to establish cannabis projects throughout the state of California. Operations will be conducted under a newly formed subsidiary, GHC Ventures.
For more information about LiveWire Ergogenics, visit http://www.livewireergogenics.com. For non-material updates, follow LiveWire Ergogenics on Twitter @livewireLVVV.
About LiveWire Ergogenics, Inc. LiveWire Ergogenics, Inc. (LVVV) specializes in identifying and monetizing current and future trends in the health and wellness industry, including the design and establishment of legal, fully controlled and contained cannabis production environments. To further this agenda, the Company is entering into select research partnerships to explore the application of cannabinoid-based products to target specific ailments or conditions with large “sufferer” populations, for human and veterinarian applications. This includes the development and licensing of high-quality cannabinoid-based products and services, the cloning of cannabis strains to produce positive medicinal results and the dosing verification of zero pesticide products for quality brands via its “7X-Pure Dosage and Verification System”. The team at LiveWire Ergogenics has a passion for research and advanced product development and is committed to generating and implementing innovative ideas to produce high-quality products that satisfy an increasing demand in this fast-growing industry.
Forward-Looking Statements Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Forward-looking statements may include, without limitation, financial projections, statements regarding the plans and objectives of management for future operations, the development, regulatory approvals and commercialization of the Company’s products, or any of the Company’s other proposed products, systems or services. Such forward-looking statements are not meant to predict or guarantee actual results and performance, events or circumstances and actual events may differ considerably. Factors that may cause actual results to differ materially from any projections may include, without limitation, the Company’s inability to obtain additional financing, delays in the development of its products, the impact of significant new or changing government regulation in the cannabis industry, existing or increased competition, results of arbitration and litigation, stock volatility and illiquidity, and the Company’s failure to implement the Company’s business plans or strategies. The Company assumes no obligation to update any forward-looking statements to reflect any event or circumstance that may arise after the date of this release.